Index Venture Life Associates Vi LTD Centessa Pharmaceuticals PLC Transaction History
Index Venture Life Associates Vi LTD
- $40 Million
- Q3 2022
A detailed history of Index Venture Life Associates Vi LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Index Venture Life Associates Vi LTD holds 9,961,789 shares of CNTA stock, worth $169 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
9,961,789
Previous 9,961,789
-0.0%
Holding current value
$169 Million
Previous $48.5 Million
17.45%
% of portfolio
100.0%
Previous 100.0%
Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
108Shares Held
118MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$338 Million66.33% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$164 Million4.42% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$106 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$101 Million8.27% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.68MShares$79.3 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...